Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
2Activity
0 of .
Results for:
No results containing your search query
P. 1
Classen Immunotherapies v. Shionogi et. al.

Classen Immunotherapies v. Shionogi et. al.

Ratings: (0)|Views: 186|Likes:
Published by PriorSmart
Official Complaint for Patent Infringement in Civil Action No. 1:13-cv-00921-RDB: Classen Immunotherapies, Inc. v. Shionogi, Inc. et. al. Filed in U.S. District Court for the District of Maryland, the Hon. Richard D Bennett presiding. See http://news.priorsmart.com/-l7SQ for more info.
Official Complaint for Patent Infringement in Civil Action No. 1:13-cv-00921-RDB: Classen Immunotherapies, Inc. v. Shionogi, Inc. et. al. Filed in U.S. District Court for the District of Maryland, the Hon. Richard D Bennett presiding. See http://news.priorsmart.com/-l7SQ for more info.

More info:

Published by: PriorSmart on Mar 27, 2013
Copyright:Public Domain

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

02/04/2014

pdf

text

original

 
UNITED STATES DISTRICT COURTFOR THE DISTRICT OF MARYLAND
CLASSEN IMMUNOTHERAPIES, INC.6517 Montrose AvenueBaltimore, Maryland 21212
Plaintiff,
vs.SHIONOGI INC.,300 Campus DriveFlorham Park, NJ 07932andMERZ PHARMACEUTICALS, LLC4215 Tudor LaneGreensboro, NC 27410
Defendants
.Civil Action No.:
13-921COMPLAINT FOR PATENTINFRINGEMENT JURY TRIAL DEMANDED
Plaintiff, Classen Immunotherapies, Inc. (“Classen”), brings this Complaint for patentinfringement against Defendants Shionogi Inc. and Merz Pharmaceuticals, LLC (collectively“Defendants”) as outlined below.
 JURISDICTION AND VENUE
1.This is an action for patent infringement under Title 35 of the United States Code§§281 and 271 (a) (b) (c) and/or (f) for infringement “during the term of the patent” both pre-and post-issuance including ongoing infringement and including “during the period beginning onthe date of publication of the application for such patent” as set forth under Title 35 of theUnited States Code §154(d) for the period beginning on June 27, 2002 for US Patent 7,984,069and August 31, 2006 for US Patent 7,653,639.2.This Court has jurisdiction over patent claims under 35 U.S.C. §281 and 28U.S.C. §§1331, 1338(a) providing for federal question jurisdiction of actions relating to patents-1-
 
and trademarks.3.Defendants are currently engaged in making, using, offering for sale and selling,inducing to use and contributing to the infringing practicing of methods, products, kits andsystems covered under the claims of the patents in suit and are currently engaged in thedistribution of products and practicing of methods which infringes the patents in suit on anongoing basis and are liable for these activities post patent issuance under 35 U.S.C. §271 (a) (b)(c) (f) and/or (g). During the period after the publication of each of the two patents in suit, butprior to the issuance of each of the patents, Defendants engaged in making, using, offering forsale and selling, inducing to use and contributing to the infringing practicing of methods,products, kits and systems covered under the claims of the patents in suit and engaged in thedistribution of products and practicing of methods which infringed the patents in suit and areliable for these activities pre-issuance under 35 U.S.C. §154 (d). Venue is proper in this Districtpursuant to 28 U.S.C. §1391(b) (c) and (d) and §1400(a) and (b). Defendants sell products inthis District.
 THE PARTIES AND GENERAL ALLEGATIONS
4.Plaintiff, Classen Immunotherapies, Inc. is a corporation existing in the State of Maryland and is the owner of United States Letters Patent Numbers 7,653,639 which publishedon August 31, 2006 and issued on January 26, 2010 and 7,984,069 which published on June 27,2002 and issued on July 19, 2011 (the “patents in suit”).5.Defendant Shionogi Inc. (“Shionogi”) is a corporation existing under the laws of the state of Delaware, with its headquarters in Florham Park, New Jersey. Defendant Shinogi,Inc. is the successor in interest to Sciele Pharma, Inc.6.In 2008, Sciele Pharma, Inc. (“Sciele”) was acquired by Shionogi & Co., Ltd., the-2-
 
parent company of Defendant Shionogi. Sciele was the assignee of record for several patentsrelating to the drug glycopyrrolate. In 2010, Sciele changed its name to Shionogi Inc. which isthe current assignee of several patents relating to the drug glycopyrrolate.7.Defendant Shionogi manufactures and distributes nationwide, pharmaceuticalproducts containing the active ingredient known as glycopyrrolate. Drug products in pillformulation which contain glycopyrrolate have been commercially available for over a decadeand have been used in the treatment of ulcers. Liquid formulation of the drug glycopyrrolateentered the market in 2010. Robinul
®
, Robinul Forte
®
, and CUVPOSA® are brand names of thedrug glycopyrrolate used by Shionogi. Between August 2003 and the present, Shionogi (and itspredecessor in interest Sciele) identified adverse event information, which Shionogicommercialized and associated with its glycopyrrolate products.8.Sciele determined that the efficacy of glycopyrrolate can be affected by thetiming of consumption of food, including the determination that glycopyrrolate should not begiven between 1 hour before to 2 hours after a meal, and protected this development throughproprietary filings, including:Patent ApplicationfiledissuedPatent No.10/644,5308-20-20038-15-20067,091,23612/325,75512-1-200812-29-20097,638,55212/648,06812-28-200910-19-20107,816,396Shionogi Inc.’s commercialization activities began in July 2010 or earlier in both theefforts to acquire intellectual property and the sales of glycopyrrolate in association with thepreviously acquired intellectual property, including the sale of the brand CUVPOSA with theaccompanying patent rights to Merz..9.Defendant Merz Pharmaceuticals, LLC (“Merz”) is a corporation existing underthe laws of the state of North Carolina, with its headquarters in Greensboro, North Carolina.-3-

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->